CGA
SRRA

Crescent Grove Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Crescent Grove Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,786
Closed -$570K – 305
2022
Q1 		$570K Hold
17,786
– – 0.06% 162
2021
Q4 		$387K Buy
+17,786
New +$387K 0.04% 201